Dupilumab Reduces COPD Exacerbations

(MedPage Today) -- WASHINGTON -- Among chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation at high risk for exacerbations despite being on standard triple therapy, adding dupilumab (Dupixent) was associated with clinically...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news